Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Fifth round generates $3.6mm for AxioMed Spine

Executive Summary

AxioMed Spine Corp. (developing orthopedic devices to repair spinal function) has raised $3.6mm in its fifth financing round to undisclosed new and returning investors. The new funding comes as the company is finishing up a pivotal study to support an FDA marketing application for its first product--the Freedom Lumbar Disc.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies